Page last updated: 2024-08-24

atorvastatin and Pulmonary Arterial Remodeling

atorvastatin has been researched along with Pulmonary Arterial Remodeling in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Dong, B; Dong, S; Li, L; Liu, Q; Shen, J; Yang, K; Zhao, Y; Zhou, X; Zhu, D1
Deng, J; He, Y; Huang, L; Li, Y; Wang, S1
Geng, J; Wang, D; Yuan, H; Zhang, Y1
Salayandia, VM; Thompson, JF; Torbey, M; Yang, LY; Yang, Y1
Gao, G; Lian, G; Lin, T; Luo, L; Wang, H; Wu, J; Xie, L1
Alves, JV; Barbosa, NC; Carvalho, KFDS; Costa, RMD; Ferreira, AAM1
Cao, W; Cui, J; Liu, J; Shi, J; Wang, Y; Wu, J; Xia, Z; Yu, B; Yu, Y; Zhao, Y1
Ceron, CS; Gerlach, RF; Guimarães, DA; Martins-Oliveira, A; Rizzi, E; Shiva, S; Tanus-Santos, JE1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JH; Kim, JS; Ko, YG; Shin, DH1
Debus, S; Eschrich, J; Hecker, M; Korff, T; Kuk, H; Meyer, R; Noppeney, T; Wagner, AH1

Trials

1 trial(s) available for atorvastatin and Pulmonary Arterial Remodeling

ArticleYear
Effect of High-Dose Statin Therapy on Drug-Eluting Stent Strut Coverage.
    Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:11

    Topics: Aged; Atorvastatin; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Pravastatin; Prospective Studies; Prosthesis Design; Republic of Korea; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Remodeling; Wound Healing

2015

Other Studies

9 other study(ies) available for atorvastatin and Pulmonary Arterial Remodeling

ArticleYear
Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats.
    Molecules (Basel, Switzerland), 2023, Feb-15, Volume: 28, Issue:4

    Topics: Animals; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Collagen; Hypertension; Interleukin-6; Losartan; Rats; Rats, Inbred SHR; Renin; Vascular Remodeling

2023
Effects of atorvastatin in suppressing pulmonary vascular remodeling in rats with chronic obstructive pulmonary disease.
    Clinics (Sao Paulo, Brazil), 2023, Volume: 78

    Topics: Animals; Atorvastatin; Female; Inflammation; Lung; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Remodeling

2023
Atorvastatin attenuates vascular remodelling in spontaneously hypertensive rats via the protein kinase D/extracellular signal-regulated kinase 5 pathway.
    Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:8

    Topics: Animals; Atorvastatin; Male; Mitogen-Activated Protein Kinase 7; Protein Kinase C; Rats; Rats, Inbred SHR; Signal Transduction; Vascular Remodeling

2020
Treatment with Atorvastatin During Vascular Remodeling Promotes Pericyte-Mediated Blood-Brain Barrier Maturation Following Ischemic Stroke.
    Translational stroke research, 2021, Volume: 12, Issue:5

    Topics: Animals; Atorvastatin; Blood-Brain Barrier; Brain Ischemia; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Pericytes; Rats; Stroke; Vascular Remodeling

2021
Influence of atorvastatin on metabolic pattern of rats with pulmonary hypertension.
    Aging, 2021, 04-22, Volume: 13, Issue:8

    Topics: Animals; Arterial Pressure; Atorvastatin; Disease Models, Animal; Fatty Acids; Glycolysis; Humans; Hypertension, Pulmonary; Lung; Male; Metabolomics; Monocrotaline; Oxidation-Reduction; Pulmonary Artery; Rats; Vascular Remodeling

2021
Atorvastatin Attenuates Vascular Remodeling in Mice with Metabolic Syndrome.
    Arquivos brasileiros de cardiologia, 2021, Volume: 117, Issue:4

    Topics: Adipose Tissue; Animals; Atorvastatin; Cytokines; Metabolic Syndrome; Mice; Vascular Remodeling

2021
Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 51, Issue:2

    Topics: Acyltransferases; Adaptor Proteins, Signal Transducing; Atorvastatin; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Gene Expression Regulation; Hippo Signaling Pathway; Humans; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA Interference; RNA, Small Interfering; Signal Transduction; Stress, Mechanical; Transcription Factors; Umbilical Arteries; Vascular Cell Adhesion Molecule-1; Vascular Remodeling; YAP-Signaling Proteins

2018
Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
    Redox biology, 2015, Volume: 6

    Topics: Animals; Aorta; Atorvastatin; Cardiovascular Agents; Collagen; Disease Models, Animal; Drug Combinations; Drug Synergism; Endothelium, Vascular; Gene Expression Regulation; Hypertension, Renovascular; Male; Matrix Metalloproteinase 2; Myocytes, Smooth Muscle; Oxidative Stress; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Sildenafil Citrate; Transforming Growth Factor beta; Vascular Remodeling

2015
Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.
    Journal of the American Heart Association, 2016, Feb-23, Volume: 5, Issue:2

    Topics: Animals; Atorvastatin; Case-Control Studies; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rosuvastatin Calcium; Signal Transduction; Time Factors; Transcription Factor AP-1; Varicose Veins; Vascular Remodeling; Veins

2016